©2024 Stanford Medicine
Biomarkers for the Detection of Lymphatic Insufficiency
Recruiting
Trial ID: NCT02375165
Purpose
Acquired lymphedema is a disease that causes chronic swelling of the limb(s). It is
frequently under-recognized or misdiagnosed. This study is designed to lead to the
development of an accurate, noninvasive, blood test to allow testing for lymphedema. This
approach is particularly useful to investigate relative responses to treatment interventions.
Official Title
Biomarkers for the Detection of Lymphatic Insufficiency
Stanford Investigator(s)
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Eligibility
Inclusion Criteria
For lymphedema participants:
- clinical diagnosis of lymphedema of at least 6 months' duration
Control participants:
- no evidence of lymphedema
Exclusion Criteria
For lymphedema participants:
- active cancer
- infection
- bleeding tendency
- active coronary artery disease
- congestive heart failure
- history of stroke or transient ischemic attack (TIA)
- uncontrolled hypertension
- renal insufficiency (serum creatinine > 1.1)
- active inflammatory or autoimmune disease (other than lymphedema)
For control participants:
- lymph node dissection
- radiation therapy
- active inflammatory disease
Intervention(s):
procedure: phlebotomy
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305